BGNE - BeiGene Ltd Stock Trading

BeiGene Ltd.(NASDAQ: BGNE) stock trading, description, contact, officers and directors.

About BeiGene Ltd.

Not available

Stock Information

BeiGene Ltd. Company Name:

BGNE Stock Symbol:

NASDAQ Market:

Get BGNE Alerts

News, Short Squeeze, Breakout and More Instantly...

BGNE - Leap Therapeutics and BeiGene Announce First Patient Dosed in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Cancer

Leap Therapeutics and BeiGene Announce First Patient Dosed in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Cancer PR Newswire CAMBRIDGE, Mass. and BEIJING, Sept. 21, 2020 CAMBRIDGE, Mass. an...
BGNE - 3 Top Biotech Picks for 2025

When it comes to astronomical returns in investing, one of the most important factors -- aside from buying the right company -- is buying your shares early, when ordinary people have never heard of the stock. Of course, there is a danger in being too early. But you can guard against that dange...
BGNE - BeiGene Presents Data at ESMO Virtual Congress 2020 on Phase 3 Trial of Tislelizumab in First-Line Non-Squamous Non-Small Cell Lung Cancer and Phase 2 Trial of Pamiparib in Advanced Ovarian Cancer

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced the first reported data from RATIONALE 304, the Phase 3 trial of its anti-PD-1 antibody tislelizumab in combination wit...